We are analyzing https://link.springer.com/article/10.1007/s10549-004-2184-0.

Title:
Efficacy of weekly paclitaxel in patients with docetaxel-resistant metastatic breast cancer | Breast Cancer Research and Treatment
Description:
Background. Partial cross-resistance to paclitaxel and docetaxel has been demonstrated in pre-clinical studies. Patients and methods. We retrospectively evaluated the efficacy of weekly paclitaxel 80 mg/m2 in 82 patients with docetaxel-resisitant metastatic breast cancer. Docetaxel resistance was classified into primary resistance, defined as progressive disease while receiving docetaxel, and secondary resistance, defined as progression after achievement of a documented clinical response to docetaxel. Secondary resistance was subclassified according to the interval between the final infusion of docetaxel and the start of weekly paclitaxel into: (1) short interval, ≦120 days, and (2) long interval, >120 days. Results. The response rate of the 82 patients was 19.5% (95% confidence interval, 10.8–27.9%). The response rate according to the docetaxel resistance category was: primary resistance (n=24), 8.3%; secondary resistance (n=58), 24.1% (short interval [n=39], 17.9%, and long interval, [n=19], 36.8%). The differences in response rates among the three categories were statistically significant (p=0.0247, Cochran–Mantel–Haenszel test). The interval between from the final docetaxel infusion and disease progression were predictors for response of weekly paclitaxel. Conclusion. Weekly paclitaxel is modestly effective and safe in docetaxel-resistant metastatic breast cancer patients. However, weekly paclitaxel should not be recommended for primary resistance patients with docetaxel.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Health & Fitness
Education
Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't figure out the monetization strategy.

Earning money isn't the goal of every website; some are designed to offer support or promote social causes. People have different reasons for creating websites. This might be one such reason. Link.springer.com might have a hidden revenue stream, but it's not something we can detect.

Keywords {🔍}

cancer, breast, docetaxel, google, scholar, pubmed, cas, paclitaxel, patients, metastatic, resistance, article, oncol, weekly, clin, efficacy, phase, treatment, interval, research, study, taxol, privacy, cookies, content, yasuhiro, response, access, publish, search, katsumata, uno, advanced, horwitz, res, author, data, information, log, journal, docetaxelresistant, yonemori, hajime, ando, fujiwara, primary, secondary, safety, discover, chemotherapy,

Topics {✒️}

anthracenedione-resistant breast cancer month download article/chapter world health organization metastatic breast cancer cochran–mantel–haenszel test fant sb horwitz ringel sb horwitz hajime uno dose-dense therapy asmar gn hortobagyi real-world study gika ma dimopoulos advanced anthracycline-resistant docetaxel resistance category privacy choices/manage cookies partial cross-resistance multidrug resistance protein breast cancer full article pdf related subjects author correspondence docetaxel successfully treated dual her2 blockade medical oncology division phase ii study primary resistance patients dose-escalation study randomized phase ii pre-clinical studies weekly paclitaxel int single-agent docetaxel check access evidence-based review exogenous guanosine 5′-triphospahate sutherland jl misset kane wa bierman buchholz ef smit kalofonos la moulopoulos seeber ym rustum instant access anthracycline resistance paclitaxel-induced remission paclitaxel-pretreated previously discontinued patients conditions privacy policy docetaxel resistance european economic area line chemotherapy yasuhiro fujiwara final docetaxel infusion

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Efficacy of weekly paclitaxel in patients with docetaxel-resistant metastatic breast cancer
         description: Background. Partial cross-resistance to paclitaxel and docetaxel has been demonstrated in pre-clinical studies. Patients and methods. We retrospectively evaluated the efficacy of weekly paclitaxel 80 mg/m2 in 82 patients with docetaxel-resisitant metastatic breast cancer. Docetaxel resistance was classified into primary resistance, defined as progressive disease while receiving docetaxel, and secondary resistance, defined as progression after achievement of a documented clinical response to docetaxel. Secondary resistance was subclassified according to the interval between the final infusion of docetaxel and the start of weekly paclitaxel into: (1) short interval, ≦120 days, and (2) long interval, >120 days. Results. The response rate of the 82 patients was 19.5% (95% confidence interval, 10.8–27.9%). The response rate according to the docetaxel resistance category was: primary resistance (n=24), 8.3%; secondary resistance (n=58), 24.1% (short interval [n=39], 17.9%, and long interval, [n=19], 36.8%). The differences in response rates among the three categories were statistically significant (p=0.0247, Cochran–Mantel–Haenszel test). The interval between from the final docetaxel infusion and disease progression were predictors for response of weekly paclitaxel. Conclusion. Weekly paclitaxel is modestly effective and safe in docetaxel-resistant metastatic breast cancer patients. However, weekly paclitaxel should not be recommended for primary resistance patients with docetaxel.
         datePublished:
         dateModified:
         pageStart:237
         pageEnd:241
         sameAs:https://doi.org/10.1007/s10549-004-2184-0
         keywords:
            docetaxel
            metastatic breast cancer
            paclitaxel
            predictive factor
            resistance
            taxane
            Oncology
         image:
         isPartOf:
            name:Breast Cancer Research and Treatment
            issn:
               1573-7217
               0167-6806
            volumeNumber:89
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Kluwer Academic Publishers
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Kan Yonemori
               affiliation:
                     name:National Cancer Center Hospital
                     address:
                        name:Breast and Medical Oncology Division, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Noriyuki Katsumata
               affiliation:
                     name:National Cancer Center Hospital
                     address:
                        name:Breast and Medical Oncology Division, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hajime Uno
               affiliation:
                     name:Kitasato University Graduate School
                     address:
                        name:Division of Biostatistics, Kitasato University Graduate School, Minato-ku, Tokyo, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Koji Matsumoto
               affiliation:
                     name:National Cancer Center Hospital
                     address:
                        name:Breast and Medical Oncology Division, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Tsutomu Kouno
               affiliation:
                     name:National Cancer Center Hospital
                     address:
                        name:Breast and Medical Oncology Division, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Shinya Tokunaga
               affiliation:
                     name:National Cancer Center Hospital
                     address:
                        name:Breast and Medical Oncology Division, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yasuhiro Yamanaka
               affiliation:
                     name:National Cancer Center Hospital
                     address:
                        name:Breast and Medical Oncology Division, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Chikako Shimizu
               affiliation:
                     name:National Cancer Center Hospital
                     address:
                        name:Breast and Medical Oncology Division, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Masashi Ando
               affiliation:
                     name:National Cancer Center Hospital
                     address:
                        name:Breast and Medical Oncology Division, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Masahiro Takeuchi
               affiliation:
                     name:Kitasato University Graduate School
                     address:
                        name:Division of Biostatistics, Kitasato University Graduate School, Minato-ku, Tokyo, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yasuhiro Fujiwara
               affiliation:
                     name:National Cancer Center Hospital
                     address:
                        name:Breast and Medical Oncology Division, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Efficacy of weekly paclitaxel in patients with docetaxel-resistant metastatic breast cancer
      description: Background. Partial cross-resistance to paclitaxel and docetaxel has been demonstrated in pre-clinical studies. Patients and methods. We retrospectively evaluated the efficacy of weekly paclitaxel 80 mg/m2 in 82 patients with docetaxel-resisitant metastatic breast cancer. Docetaxel resistance was classified into primary resistance, defined as progressive disease while receiving docetaxel, and secondary resistance, defined as progression after achievement of a documented clinical response to docetaxel. Secondary resistance was subclassified according to the interval between the final infusion of docetaxel and the start of weekly paclitaxel into: (1) short interval, ≦120 days, and (2) long interval, >120 days. Results. The response rate of the 82 patients was 19.5% (95% confidence interval, 10.8–27.9%). The response rate according to the docetaxel resistance category was: primary resistance (n=24), 8.3%; secondary resistance (n=58), 24.1% (short interval [n=39], 17.9%, and long interval, [n=19], 36.8%). The differences in response rates among the three categories were statistically significant (p=0.0247, Cochran–Mantel–Haenszel test). The interval between from the final docetaxel infusion and disease progression were predictors for response of weekly paclitaxel. Conclusion. Weekly paclitaxel is modestly effective and safe in docetaxel-resistant metastatic breast cancer patients. However, weekly paclitaxel should not be recommended for primary resistance patients with docetaxel.
      datePublished:
      dateModified:
      pageStart:237
      pageEnd:241
      sameAs:https://doi.org/10.1007/s10549-004-2184-0
      keywords:
         docetaxel
         metastatic breast cancer
         paclitaxel
         predictive factor
         resistance
         taxane
         Oncology
      image:
      isPartOf:
         name:Breast Cancer Research and Treatment
         issn:
            1573-7217
            0167-6806
         volumeNumber:89
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Kluwer Academic Publishers
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Kan Yonemori
            affiliation:
                  name:National Cancer Center Hospital
                  address:
                     name:Breast and Medical Oncology Division, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Noriyuki Katsumata
            affiliation:
                  name:National Cancer Center Hospital
                  address:
                     name:Breast and Medical Oncology Division, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hajime Uno
            affiliation:
                  name:Kitasato University Graduate School
                  address:
                     name:Division of Biostatistics, Kitasato University Graduate School, Minato-ku, Tokyo, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Koji Matsumoto
            affiliation:
                  name:National Cancer Center Hospital
                  address:
                     name:Breast and Medical Oncology Division, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Tsutomu Kouno
            affiliation:
                  name:National Cancer Center Hospital
                  address:
                     name:Breast and Medical Oncology Division, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Shinya Tokunaga
            affiliation:
                  name:National Cancer Center Hospital
                  address:
                     name:Breast and Medical Oncology Division, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yasuhiro Yamanaka
            affiliation:
                  name:National Cancer Center Hospital
                  address:
                     name:Breast and Medical Oncology Division, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Chikako Shimizu
            affiliation:
                  name:National Cancer Center Hospital
                  address:
                     name:Breast and Medical Oncology Division, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Masashi Ando
            affiliation:
                  name:National Cancer Center Hospital
                  address:
                     name:Breast and Medical Oncology Division, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Masahiro Takeuchi
            affiliation:
                  name:Kitasato University Graduate School
                  address:
                     name:Division of Biostatistics, Kitasato University Graduate School, Minato-ku, Tokyo, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yasuhiro Fujiwara
            affiliation:
                  name:National Cancer Center Hospital
                  address:
                     name:Breast and Medical Oncology Division, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Breast Cancer Research and Treatment
      issn:
         1573-7217
         0167-6806
      volumeNumber:89
Organization:
      name:Kluwer Academic Publishers
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:National Cancer Center Hospital
      address:
         name:Breast and Medical Oncology Division, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
         type:PostalAddress
      name:National Cancer Center Hospital
      address:
         name:Breast and Medical Oncology Division, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
         type:PostalAddress
      name:Kitasato University Graduate School
      address:
         name:Division of Biostatistics, Kitasato University Graduate School, Minato-ku, Tokyo, Japan
         type:PostalAddress
      name:National Cancer Center Hospital
      address:
         name:Breast and Medical Oncology Division, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
         type:PostalAddress
      name:National Cancer Center Hospital
      address:
         name:Breast and Medical Oncology Division, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
         type:PostalAddress
      name:National Cancer Center Hospital
      address:
         name:Breast and Medical Oncology Division, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
         type:PostalAddress
      name:National Cancer Center Hospital
      address:
         name:Breast and Medical Oncology Division, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
         type:PostalAddress
      name:National Cancer Center Hospital
      address:
         name:Breast and Medical Oncology Division, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
         type:PostalAddress
      name:National Cancer Center Hospital
      address:
         name:Breast and Medical Oncology Division, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
         type:PostalAddress
      name:Kitasato University Graduate School
      address:
         name:Division of Biostatistics, Kitasato University Graduate School, Minato-ku, Tokyo, Japan
         type:PostalAddress
      name:National Cancer Center Hospital
      address:
         name:Breast and Medical Oncology Division, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Kan Yonemori
      affiliation:
            name:National Cancer Center Hospital
            address:
               name:Breast and Medical Oncology Division, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
               type:PostalAddress
            type:Organization
      name:Noriyuki Katsumata
      affiliation:
            name:National Cancer Center Hospital
            address:
               name:Breast and Medical Oncology Division, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
               type:PostalAddress
            type:Organization
      name:Hajime Uno
      affiliation:
            name:Kitasato University Graduate School
            address:
               name:Division of Biostatistics, Kitasato University Graduate School, Minato-ku, Tokyo, Japan
               type:PostalAddress
            type:Organization
      name:Koji Matsumoto
      affiliation:
            name:National Cancer Center Hospital
            address:
               name:Breast and Medical Oncology Division, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
               type:PostalAddress
            type:Organization
      name:Tsutomu Kouno
      affiliation:
            name:National Cancer Center Hospital
            address:
               name:Breast and Medical Oncology Division, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
               type:PostalAddress
            type:Organization
      name:Shinya Tokunaga
      affiliation:
            name:National Cancer Center Hospital
            address:
               name:Breast and Medical Oncology Division, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
               type:PostalAddress
            type:Organization
      name:Yasuhiro Yamanaka
      affiliation:
            name:National Cancer Center Hospital
            address:
               name:Breast and Medical Oncology Division, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
               type:PostalAddress
            type:Organization
      name:Chikako Shimizu
      affiliation:
            name:National Cancer Center Hospital
            address:
               name:Breast and Medical Oncology Division, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
               type:PostalAddress
            type:Organization
      name:Masashi Ando
      affiliation:
            name:National Cancer Center Hospital
            address:
               name:Breast and Medical Oncology Division, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
               type:PostalAddress
            type:Organization
      name:Masahiro Takeuchi
      affiliation:
            name:Kitasato University Graduate School
            address:
               name:Division of Biostatistics, Kitasato University Graduate School, Minato-ku, Tokyo, Japan
               type:PostalAddress
            type:Organization
      name:Yasuhiro Fujiwara
      affiliation:
            name:National Cancer Center Hospital
            address:
               name:Breast and Medical Oncology Division, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Breast and Medical Oncology Division, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
      name:Breast and Medical Oncology Division, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
      name:Division of Biostatistics, Kitasato University Graduate School, Minato-ku, Tokyo, Japan
      name:Breast and Medical Oncology Division, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
      name:Breast and Medical Oncology Division, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
      name:Breast and Medical Oncology Division, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
      name:Breast and Medical Oncology Division, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
      name:Breast and Medical Oncology Division, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
      name:Breast and Medical Oncology Division, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
      name:Division of Biostatistics, Kitasato University Graduate School, Minato-ku, Tokyo, Japan
      name:Breast and Medical Oncology Division, Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(94)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.26s.

LINK . SPRINGER . COM {}